Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway

P. Dvorak, L. Chrast, PI. Nikel, R. Fedr, K. Soucek, M. Sedlackova, R. Chaloupkova, V. de Lorenzo, Z. Prokop, J. Damborsky,

. 2015 ; 14 (-) : 201. [pub] 20151221

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This burden originates from a combination of stresses that may include competition for the expression machinery, side-reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermediates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such harsh conditions is often overlooked. RESULTS: The physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected negative synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the effect was due to the original inducer's chemical properties. CONCLUSIONS: IPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its content of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of P lac , dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This suggests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16027818
003      
CZ-PrNML
005      
20161025122517.0
007      
ta
008      
161005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12934-015-0393-3 $2 doi
024    7_
$a 10.1186/s12934-015-0393-3 $2 doi
035    __
$a (PubMed)26691337
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dvorak, Pavel $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. pdvorak@cnb.csic.es. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. pdvorak@cnb.csic.es.
245    10
$a Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway / $c P. Dvorak, L. Chrast, PI. Nikel, R. Fedr, K. Soucek, M. Sedlackova, R. Chaloupkova, V. de Lorenzo, Z. Prokop, J. Damborsky,
520    9_
$a BACKGROUND: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This burden originates from a combination of stresses that may include competition for the expression machinery, side-reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermediates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such harsh conditions is often overlooked. RESULTS: The physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected negative synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the effect was due to the original inducer's chemical properties. CONCLUSIONS: IPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its content of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of P lac , dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This suggests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3).
650    _2
$a Escherichia coli $x metabolismus $7 D004926
650    _2
$a isopropylthiogalaktosid $x škodlivé účinky $x genetika $7 D007544
650    _2
$a metabolické inženýrství $7 D060847
650    _2
$a metabolické sítě a dráhy $x genetika $7 D053858
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chrast, Lukas $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. chr@mail.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. chr@mail.muni.cz.
700    1_
$a Nikel, Pablo I $u Systems and Synthetic Biology Program, Centro Nacional de Biotecnología CNB-CSIC, Cantoblanco, 28049, Madrid, Spain. pablo.nikel@cnb.csic.es.
700    1_
$a Fedr, Radek $u International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. fedr@ibp.cz. Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Kralovopolska 135, 612 65, Brno, Czech Republic. fedr@ibp.cz.
700    1_
$a Soucek, Karel $u International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. ksoucek@ibp.cz. Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Kralovopolska 135, 612 65, Brno, Czech Republic. ksoucek@ibp.cz. Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic. ksoucek@ibp.cz.
700    1_
$a Sedlackova, Miroslava $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic. msedl@med.muni.cz.
700    1_
$a Chaloupkova, Radka $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. radka@chemi.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. radka@chemi.muni.cz.
700    1_
$a de Lorenzo, Víctor $u Systems and Synthetic Biology Program, Centro Nacional de Biotecnología CNB-CSIC, Cantoblanco, 28049, Madrid, Spain. vdlorenzo@cnb.csic.es.
700    1_
$a Prokop, Zbynek $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. zbynek@chemi.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. zbynek@chemi.muni.cz.
700    1_
$a Damborsky, Jiri $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00, Brno, Czech Republic. jiri@chemi.muni.cz. International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 656 91, Brno, Czech Republic. jiri@chemi.muni.cz.
773    0_
$w MED00008244 $t Microbial cell factories $x 1475-2859 $g Roč. 14, č. - (2015), s. 201
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26691337 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161025122931 $b ABA008
999    __
$a ok $b bmc $g 1166132 $s 952448
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 14 $c - $d 201 $e 20151221 $i 1475-2859 $m Microbial cell factories $n Microb Cell Fact $x MED00008244
LZP    __
$a Pubmed-20161005

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...